GBM AGILE trial knowledge reveals clinically significant enchancment in a prespecified secondary evaluation for general survival in paxalisib-treated, newly identified unmethylated sufferers with...
Growth of a medical assay for immuno-oncologic profiling of pediatric mind tumorsTo develop a clinically-validated purposeful genomic assay we designed a 103-gene immuno-oncology...